23.3 C
New York
Thursday, September 23, 2021

Here’s Why Lifting Acasti Pharma (ACST) Is Making Sharp Gains

The stock of Acasti Pharma (NASDAQ: ACST) increased by 16.75% on Tuesday before the opening bell. The rise followed a decline of -0.84% or -$0.01 per share in regular session and an update on the use of the company’s equity offering.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


What was the update?

Acasti is a biopharmaceutical company with a documented history of researching, developing, and commercializing prescription drugs using OM3 fatty acids delivered both free on the liposome and bound to phospholipids.

Last day Acasti Pharma provided an update on the use of its “at-the market” equity offering program as required pursuant to the policies of the TSX Venture Exchange.

  • The Acasti entered into an amended and restated ATM sales agreement with three of its agents on June 29, 2020 to implement an “at-the-market” equity offering program.
  • Those include H.C. Wainwright & Co., LLC, Oppenheimer & Co. Inc. and Riley FBR Inc.
  • Acasti will be permitted to sell certain of its common shares having an aggregate offering price of up to $75 million through those Agents under this “ATM Program”.
  • Based on the ATM Program, Acasti has distributed an aggregate of 20,159,229 common shares since last distribution reported on January 27, 2021, with gross proceeds of US$21.70 million to the Company.
  • At an average market price of $1.0747 per share, ATM shares were sold at prevailing market prices.
  • To the best of the Company’s knowledge, no securities were offered for purchase on the TSXV or in Canada.
  • A registration statement on Form S-3 as of July 7, 2020 was used in conjunction with a Sales Agreement for the sale of the ATM Shares.
  • A commission of 3.0% of the aggregate gross proceeds raised for services provided by the Agents was paid to them in accordance with the Sales Agreement.
  • The ATM sales recently concluded resulted in a total number of shares outstanding equal to 200,119,659 as of March 5, 2021.
  • Acasti has strengthened its balance sheet with the additional funding which will provide the company with flexibility in evaluating important strategic alternatives in its ongoing review process.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.